AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery. - Wikidata - wikimedia - TriplyDB

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

http://www.wikidata.org/entity/Q34276778

about

Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer.Nanotechnology-based approaches in anticancer research Enhanced Entrapment and Improved in Vitro Controlled Release of N-Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self-Assembly Method.Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects.Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy.G4-Tetra DNA Duplex Induce Lung Cancer Cell Apoptosis in A549 Cells Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles.Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.Lipid-enveloped hybrid nanoparticles for drug delivery.Concepts and practices used to develop functional PLGA-based nanoparticulate systems Application of aptamers for targeted therapeutics.Aptamers: problems, solutions and prospects.Oligonucleotide aptamers: new tools for targeted cancer therapy.Aptamers as drug delivery vehicles.Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.Targeting cancer cells with controlled release nanocapsules based on a single aptamer.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Lipid-coated polymeric nanoparticles for cancer drug delivery.Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.Structurally distinct hybrid polymer/lipid nanoconstructs harboring a type-I ribotoxin as cellular imaging and glioblastoma-directed therapeutic vectors.Aptamers as Therapeutics.Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.Nanoparticle Functionalization and Its Potentials for Molecular Imaging.Biodegradable Self-Assembled Nanoparticles of Galactose-Containing Amphiphilic Triblock Copolymers for Targeted Delivery of Paclitaxel to HepG2 Cells.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.

P2860

Q26783705-D617FC88-04C5-40A4-8E36-87F7C52DA4AE Q26995510-5D724893-C06B-4C3F-8F61-577234F88DB0 Q30434521-844B6FF4-07E9-468D-B717-4800A7550F18 Q33681168-B273D609-50B3-4C20-9DA4-3ED12DD9F2E4 Q33834772-74C26517-1D42-4813-AE97-A4B40AB449D4 Q34698624-C627646D-7FBF-42C7-8144-D786AC828964 Q36023716-F00D7068-B73F-4BFB-AD91-BF73BE2E96A6 Q36028980-75772F0D-0A25-4406-BF1B-586C46C599CA Q36078293-307DEC6B-F338-4303-8637-F833A0615871 Q36168983-2DEF6AD3-49A5-479B-BE83-EFB301D3114B Q36350003-CE0541ED-A857-4C23-AE29-FD7E9DF0BB0D Q36644318-B6C9DF78-2F10-4E8D-A6B2-25E7AE58C07D Q36946804-DF0E1188-01BD-4DD8-A660-3F8E546DBD08 Q36986485-A2DDE1AB-2222-4D99-85C0-52C6989AB7ED Q37301975-C5F1A0AC-A13A-49A7-9442-5CF4A3E9D979 Q37316779-F75EBF20-E978-4965-A991-70D18014EB82 Q37607750-95A9C5EA-B51E-40AF-BA61-599AC5C1F53A Q37677464-C8F7A3B9-2368-4854-8ACF-9597A74433FB Q38071910-C6B70076-8B3B-49CF-9CB3-E932DAA36510 Q38086377-BD2318A1-CABD-4097-AA1E-5CCD707F9BB5 Q38096870-EBBEAC0C-EF33-4859-9FBA-79A70AF92375 Q38181121-55A2CA9B-05EC-4FD3-BD33-F8CC937F7DBC Q38237132-8138AE26-CDE9-49C0-ACA7-88250FB0FE94 Q38240594-571C706B-F539-4630-B737-849CFD8B8609 Q38311680-176B24E4-7016-453B-9C84-9B7AE853FB5B Q38318762-AD009D4A-3078-42B0-86D8-AD3C4C87C8D9 Q38491805-99BE1E1C-4FE1-4BDB-BE52-E2428244DA3E Q38494470-6003B774-ECF6-4B89-B732-2ED8C9A2D84C Q38504825-879EADD9-1F95-4B72-BEDC-AE87E7FEDFE1 Q38556750-9B1E5750-B55D-48CC-BE7E-E73822B89144 Q38682986-A69BBEEC-881B-4463-8D53-42CC0719AAAF Q38960506-6804E70C-4BC0-4640-A511-BC64C2EC7650 Q39070782-F5A87B6B-B283-457F-A765-D74E8059D7B3 Q39123634-38512832-5EC7-466E-AB5B-2781DCB730C2 Q39194848-56D59C33-DA44-445D-9CEA-E22A3E32C3C4 Q40034701-7CF36C96-4A9D-421A-924E-623F38CA9596 Q41953738-22AD3C1F-EBF6-4A11-8EDF-AEA7FD7B06B5 Q48025703-E9945CDD-339B-4AEF-B13B-C75BF26A481A Q48257489-4B155BB8-2A9D-430E-A21A-69DA4DDDBB60 Q54457076-C590838F-ABD0-498D-8867-0ED7B1C89A8A

P2860

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

http://www.wikidata.org/entity/Q34276778

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@ast

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@en

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@nl

type

label

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@ast

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@en

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@nl

prefLabel

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@ast

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@en

AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.

@nl

P1433

Q34276778-BBC48148-B74F-4512-A34D-7934DB6D7BB4

P1476

Q34276778-D61C9980-E736-44B5-A5BA-E63CCB0FDE3F

P2093

Q34276778-2A334945-881D-4930-975A-D1DE360D5E87

Q34276778-3EA01135-A03B-4557-920E-3872533D2326

Q34276778-47EA7DAB-B780-44CD-86A9-EA2F9F3852FB

Q34276778-68AF06FB-CF03-478A-A5F4-D0397BCAB637

Q34276778-6C198CC8-8D0F-4DF9-A75B-8702DE5A2A17

Q34276778-D83A7CE2-1A53-4F8B-9E30-C0F039544D79

Q34276778-FC0D9FDD-DB5B-4F8D-89D3-354BA18514D3

P2860

Q34276778-001F9B19-BAF2-4CC7-8CFE-0B4EC59F8747

Q34276778-142EC12A-D0FD-41C7-BB8E-9DF7DDF56EC3

Q34276778-232A0154-87AE-43D4-9AF4-0C1F72FCBF0F

Q34276778-24C53288-3752-46D7-AC16-7DDAAB76C542

Q34276778-278AC302-60C6-4125-ADD4-3D2D8F63A541

Q34276778-2DDA4DB2-D5AB-428C-AC05-1C6443DA51D7

Q34276778-2FF7624F-83C8-478C-93D2-48BB3EC5ECC0

Q34276778-35D9C8C1-1E21-4220-ABE9-0A2A82C4511A

Q34276778-4AE303A4-5C64-41E1-9219-F1C48B83B4C5

Q34276778-73A23607-F7FD-44F2-A3F2-9BF1375D19AB

P304

Q34276778-930A6AAE-80C4-44A7-A919-4AA8F1289E29

P31

Q34276778-8695FBC9-423A-416F-B887-19EDE4C6014C

P356

Q34276778-8FBD7E9B-C576-4A41-BEB7-0D65CA0E54DB

P433

Q34276778-4A62F2B6-52F3-4136-A852-CBA13D666254

P478

Q34276778-D4191D63-1B7A-453E-BF8E-E4745481C74D

P50

Q34276778-479213DF-7626-49C4-BE65-EEEA610F591F

P577

Q34276778-47000C97-3EA9-4208-9896-593F63146326

P698

Q34276778-6C61CAF7-2512-415C-8973-0AF3CD4DA3E8

P921

Q34276778-7EF304E8-7823-4517-A325-1D04C57C0F98

Q34276778-E967978A-4B4C-46BA-8B9D-D0E19A9C6E73

P356

P1433

Biotechnology and Bioengineering

P1476

AS1411 aptamer tagged PLGA-lec ...... ll targeting and drug delivery

@en

P2093

Athulya Aravind

http://www.w3.org/2001/XMLSchema#string

Prashanti Jeyamohan

http://www.w3.org/2001/XMLSchema#string

Remya Nair

http://www.w3.org/2001/XMLSchema#string

Srivani Veeranarayanan

http://www.w3.org/2001/XMLSchema#string

Toru Maekawa

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Yutaka Nagaoka

http://www.w3.org/2001/XMLSchema#string

P2860

Liposome-based drug delivery in breast cancer treatment

Discovery and development of anticancer aptamers

Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro

Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.

Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.

Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation.

Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.

Endocytosis of nanomedicines.

In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles

P304

2920-2931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIT.24558

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22615073

http://www.w3.org/2001/XMLSchema#string

P921